DVAX: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -21.32%.However, over the last six months, we can see a stronger performance of -16.67%. Over the last 30 days, the price of DVAX has leaped by -5.90%. And in the last five days, it has fallen by -6.46%.

Dynavax Technologies Corp. experienced a rather steady stock market performance. The highest value in the past year was recorded at $15.15 on 11/03/23 and the lowest value was $10.48 on 05/09/24.

52-week price history of DVAX Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dynavax Technologies Corp.’s current trading price is -27.39% away from its 52-week high, while its distance from the 52-week low is 4.96%. The stock’s price range during this period has varied between$10.48 and $15.15. The Dynavax Technologies Corp.’s shares, which operate in the Healthcare, saw a trading volume of around 3.18 million for the day, a figure considerably higher than their average daily volume of 2.06 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Dynavax Technologies Corp. (DVAX) has experienced a quarterly decline of -10.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.44B and boasts a workforce of 408 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 12.66, with a change in price of -2.83. Similarly, Dynavax Technologies Corp. recorded 2,019,771 in trading volume during the last 100 days, posting a change of -20.46%.

DVAX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DVAX stands at 0.41. Similarly, the long-term debt-to-equity ratio is also 0.41.

DVAX Stock Stochastic Average

Dynavax Technologies Corp.’s raw stochastic average for the past 50 days is presently 18.67%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 32.50%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.50% and 30.20%, respectively.

Most Popular